Physician profile
Bryan D Anderson
NPI 1023417581
$1,336.71
in general payments reported to CMS, 2019-2025
9 companies · $57.56 in 2025
The $57.56 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $422 · 2022: $339 · 2023: $194 · 2024: $324 · 2025: $57.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $575.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $535.34 | 2021-2024 | Perclot, Preveleak, Floseal |
| Atricure, INC. | $200.28 | 2022 | |
| Davol INC. | $157.37 | 2021 | |
| La Jolla Pharmaceutical Company | $122.28 | 2023 | Giapreza |
| Saphena Medical, INC. | $100.61 | 2021 | |
| Abiomed | $84.85 | 2024-2025 | Impella |
| Medtronic, INC. | $58.43 | 2022-2024 | Invos |
| Ethicon US, LLC | $42.48 | 2024-2025 | Echelon Endopath, Echelon Flex, Surgicel Nu-Knit |
| Edwards Lifesciences Corporation | $35.07 | 2023 | Konect Resilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.